Wind and solar power generation will continue to grow in the energy supply of the future, but its inherent variability (intermittency) requires appropriate energy systems for storing and using power. Storage of possibly temporary excess of power as methane from hydrogen gas and carbon dioxide is a promising option. With electrolysis hydrogen gas can be generated from (renewable) power. The combination of such hydrogen with carbon dioxide results in the energy carrier methane that can be handled well and may may serve as carbon feedstock of the future. Biogas from biomass delivers both methane and carbon dioxide. Anaerobic microorganisms can make additional methane from hydrogen and carbon dioxide in a biomethanation process that compares favourably with its chemical counterpart. Biomethanation for renewable power storage and use makes appropriate use of the existing infrastructure and knowledge base for natural gas. Addition of hydrogen to a dedicated biogas reactor after fermentation optimizes the biomethanation conditions and gives maximum flexibility. The low water solubility of hydrogen gas limits the methane production rate. The use of hollow fibers, nano-bubbles or better-tailored methane-forming microorganisms may overcome this bottleneck. Analyses of patent applications on biomethanation suggest a lot of freedom to operate. Assessment of biomethanation for economic feasibility and environmental value is extremely challenging and will require future data and experiences. Currently biomethanation is not yet economically feasible, but this may be different in the energy systems of the near future.
DOCUMENT
The increased cultivation of highly productive C4 crop plants may contribute to a second green revolution in agriculture. However, the regulation of mineral nutrition is rather poorly understood in C4 plants. To understand the impact of C4 photosynthesis on the regulation of sulfate uptake by the root and sulfate assimilation into cysteine at the whole plant level, seedlings of the monocot C4 plant maize (Zea mays) were exposed to a non-toxic level of 1.0 µl l−1 atmospheric H2S at sulfate-sufficient and sulfate-deprived conditions. Sulfate deprivation not only affected growth and the levels of sulfur- and nitrogen-containing compounds, but it also enhanced the expression and activity of the sulfate transporters in the root and the expression and activity of APS reductase (APR) in the root and shoot. H2S exposure alleviated the establishment of sulfur deprivation symptoms and seedlings switched, at least partly, from sulfate to H2S as sulfur source. Moreover, H2S exposure resulted in a downregulation of the expression and activity of APR in both shoot and root, though it hardly affected that of the sulfate transporters in the root. These results indicate that maize seedlings respond similarly to sulfate deprivation and atmospheric H2S exposure as C3 monocots, implying that C4 photosynthesis in maize is not associated with a distinct whole plant regulation of sulfate uptake and assimilation into cysteine.
DOCUMENT
The 'AgroCycle' project investigates whether a cooperation of farms can become self-sufficient in energy and fertilization by using manure and organic waste streams for the production of energy, green fuel and green fertilizers by means of anaerobic digestion (AD). In the project, the project partners aim to link the nutrient cycle (from manure to digestate to green fertilizer) to a self-sufficient energy system (biomass to biogas to green fuel for processing the land) through the combined production of biogas and green fertilizers. The financial feasibility of a bio-digester is highly dependent on the use and economic value of the digestate. This combined approach increases both feasibility and sustainability (environmental impacts and CO2 emissions). To explore the feasibility of the aforementioned concept, use is made of the existing 'BioGas simulator' model developed by Hanze UAS to simulate the technical process of decentralized production of biogas and the economic cost.
DOCUMENT
Hyperhomocysteinemia is a risk factor for cardiovascular disease, neurological disorders, and bone abnormalities. The key enzyme in homocysteine metabolism, cystathionine-β-synthase (CBS) is recognized as a target for new homocysteine-lowering therapies including enzyme replacement and gene therapy. Currently, there are no pharmacotherapies available that enhance CBS activity through its allosteric mechanism. The only known allosteric activator of CBS is S-adenosyl-L-methionine (SAM), which is available as a food supplement, but its effectiveness is limited by low membrane permeability and universal involvement in methylation reactions as a substrate. The discovery of CBS activators in high-throughput screening is challenging due to a lack of dedicated assays. Available HTS-compatible activity assays for CBS rely on measuring the product hydrogen sulfide or methanethiol where the signal increases with increased CBS activity. In the case of fluorescence-based assays, it is challenging to discern activators from autofluorescent compounds. In this study, we introduce a homocysteine consumption assay for isolated human CBS (HconCBS) based on the absorbance of Ellman's reagent. This assay leverages a decrease in signal upon CBS activation, with performance parameters exceeding the requirements for high-throughput screening. In a commercial library of 3010 compounds, the HconCBS assay identified 10 hit compounds as more active than SAM, whereas a fluorescence-based assay using 7-azido-4-methylcoumarin (AzMC) identified 141 hits. HconCBS identified 101 compounds with autoabsorbance which did not include hit compounds, while the fluorescence-based assay identified 383 autofluorescent compounds which included all hit compounds. While 4 out of 10 HconCBS hits were confirmed when purchased from a new source, the compounds affected homocysteine rather than CBS. Nevertheless, HconCBS consistently detected the CBS activator seleno-adenosyl-L-methionine (SeAM) added to 4 library plates and re-discovered the same library hits in 3 out of 4 re-screened plates. Taken together, HconCBS was designed to enable the discovery of allosteric CBS activators with greater reliability than fluorescence-based methods. Despite identifying some compounds that acted on homocysteine rather than CBS, the assay consistently identified the CBS activators SAM and SeAM and demonstrated reproducibility across two screening rounds. These findings establish HconCBS as a valuable tool for identifying potential therapeutic candidates for hyperhomocysteinemia, addressing a key gap in the development of CBS-targeted pharmacotherapies.
LINK
